通过SARS-CoV-2 NSP1对抗病毒基因的表观遗传抑制
Dimitrios G Anastasakis1, Daniel Benhalevy1, Nicolas Çuburu2
1RNA Molecular Biology Laboratory, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
PloS one
|January 26, 2024
概括
严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 非结构蛋白1 (NSP1) 使用表观遗传修饰来抑制免疫基因转录. 抑制这种机制恢复了抗病毒基因表达和有限的病毒复制.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 使用像非结构蛋白1 (NSP1) 这样的病毒蛋白来逃避宿主天生的免疫力.
- 虽然NSP1在抑制宿主mRNA翻译中的作用已知,但其精确的免疫逃避机制尚未完全理解.
研究的目的:
- 阐明SARS-CoV-2 NSP1有助于免疫逃避的表观遗传机制.
- 调查针对这些表观遗传途径进行治疗干预的潜力.
主要方法:
- 在A549细胞中,RNA测序 (RNA-seq),核糖体足迹和ChIP测序 (ChIP-seq) 的整合.
- 使用G9a/GLP H3K9甲基转移酶抑制剂 (UNC0638) 来评估治疗潜力.
主要成果:
- 发现SARS-CoV-2 NSP1主要抑制免疫相关基因的转录.
- 这种抑制是通过促进Histone 3 Lysine 9二甲基化 (H3K9me2) 来调节的.
- 抑制G9a/GLP恢复了抗病毒基因的表达,并显著限制了SARS-CoV-2的复制.
结论:
- 这项研究揭示了SARS-CoV-2 NSP1.1采用的宿主免疫逃避的新型表观遗传机制.
- 针对H3K9me2表观遗传途径提供了针对SARS-CoV-2感染的潜在治疗策略.
- 了解这些表观遗传因素可以为病毒感染和免疫调节性疾病的治疗提供信息.
相关概念视频
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Immune Response Against Viral Pathogens
783
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
783


